Top House Democrat Moves to Block Trump’s $2.8 Billion Bomb Sale to Israel

Gregory Meeks is withholding approval for a proposed shipment of 40,000 heavy bombs, citing civilian-safety and legal concerns, but the Trump administration may still have a path around congressional resistance.

WASHINGTON, Sept. 17, 2026 — A senior House Democrat is attempting to halt the Trump administration’s proposed $2.8 billion sale of heavy bombs to Israel, opening another congressional fight over American military support.

Rep. Gregory Meeks of New York, the ranking Democrat on the House Foreign Affairs Committee, announced Wednesday that he would not clear the proposed sale during Congress’s informal review process.

Meeks said he has “grave, unresolved concerns” about how Israel could use the weapons in densely populated areas of Gaza and Lebanon, particularly regarding civilian protection and compliance with American law.

The proposed package is unusually significant because it contains 40,000 2,000-pound bombs, among the heaviest conventional air-dropped weapons routinely available to the Israeli military.

 

 

 

According to U.S. officials cited by AP, the package consists of 20,000 Mk84 bombs and 20,000 BLU-117 bombs, with the overall transaction valued at approximately $2.8 billion.

Both weapons weigh approximately 2,000 pounds and are designed to produce powerful explosive effects, making their use in densely populated environments particularly controversial because of the potential consequences for nearby civilians.

Congress was informally notified about the pending transaction this week. The package is not yet final, meaning Meeks’ announcement represents an objection during the review process rather than cancellation of an approved transfer.

Most of the purchase would be financed through U.S. Foreign Military Financing, under which American government funds provided to Israel are used to purchase weapons and military equipment from U.S. suppliers.

Meeks emphasized that his objection does not represent opposition to Israel’s security or its right to defend itself against regional threats, drawing a distinction between defensive assistance and this particular weapons package.

Instead, he said the Trump administration had failed to provide sufficient assurances that Netanyahu’s government would use the bombs consistently with U.S. law and appropriate safeguards for civilians.

The weapons themselves have a politically sensitive history. President Joe Biden’s administration previously paused delivery of a shipment of 2,000-pound bombs because of concerns about potential mass casualties during Israeli operations in Gaza.

Trump reversed that hold after returning to office in 2025, restoring deliveries while arguing that Israel should receive weapons purchased or promised by the United States.

The Trump administration subsequently approved additional weapons packages for Israel, including a nearly $3 billion transaction containing more than 35,500 heavy bombs after bypassing the normal congressional review procedure.

That precedent is particularly important now because Meeks’ hold may delay or complicate the latest transaction without necessarily preventing the administration from ultimately proceeding with it.

 

 

 

Once the administration formally notifies Congress, Secretary of State Marco Rubio could potentially invoke an emergency national-security determination to bypass the ordinary congressional review process, according to AP.

Rubio has previously used that authority involving Israel. AP reports that the administration bypassed normal review for a nearly $3 billion Israeli arms sale last year before approving another $6.67 billion series of sales in January.

The State Department had not publicly responded to AP’s requests for comment about either the latest proposed transaction or Meeks’ decision to withhold approval when the agency reported Wednesday.

The congressional dispute arrives amid continuing controversy surrounding Israel’s military operations in Gaza following the Hamas-led October 7, 2023 attack and the years of fighting that followed.

Tens of thousands of Palestinians have been reported killed during the conflict, while large sections of Gaza have been devastated and humanitarian conditions have generated sustained international criticism of Israel’s conduct.

A U.S.-brokered ceasefire remains fragile, with violence continuing despite the agreement and Israel saying some subsequent military actions have responded to violations by Hamas.

The latest arms package also comes after tensions periodically emerged between Trump and Israeli Prime Minister Benjamin Netanyahu, particularly surrounding the Iran conflict earlier this year.

Those disagreements have not fundamentally interrupted military cooperation. The proposed $2.8 billion package demonstrates that Washington continues seeking to substantially expand Israel’s weapons stocks under Trump.

Meeks has confronted similar questions before. In 2024, he temporarily withheld approval for a major Biden administration arms package involving Israel while seeking assurances concerning humanitarian conditions and civilian casualties.

His current objection is therefore narrower than some social-media descriptions suggesting “Democrats have blocked Trump’s Israel weapons transfer.” One senior House Democrat has placed a hold; the transaction itself remains unresolved.

Bernie Sanders, prominently featured in the graphic you provided, is also not the lawmaker responsible for Wednesday’s hold. Meeks holds the relevant House Foreign Affairs Committee position involved in this review.

Sanders has separately pursued congressional efforts opposing other U.S. weapons transfers to Israel, which may explain why social-media graphics sometimes place him at the center of the broader political dispute.

The formal process matters because Congress has several mechanisms for challenging arms sales, but preventing a determined president from completing a transaction can require significantly more than opposition from individual lawmakers.

If lawmakers eventually passed legislation formally blocking a sale and Trump vetoed it, Congress would need the constitutionally required two-thirds majorities in both chambers to override that presidential veto.

The immediate question is therefore not simply whether Democrats oppose the bombs. It is whether Meeks’ hold produces additional negotiations, changes to the package, broader congressional opposition or an administration decision to bypass review.